Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute Effect of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects

NCT00344955 is registered in ClinicalTrials.gov with Regional Hospital Holstebro as lead sponsor.

NCT NCT00344955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00344955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acute Effect of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects
Lead sponsor
Regional Hospital Holstebro
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2003
Completion date
December 31, 2003
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy